ANETA CAPRARU: Open Payments
NPI 1205519832 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,664 in 95 payments from 17 companies in 2025. Trend: 2023 $213 · 2024 $651 · 2025 $3,664
Food & beverage: $3,567Education: $97
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $701 |
| ABBVIE INC. | 16 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $516 |
| Novo Nordisk Inc | 5 | $415 |
| Janssen Biotech, Inc. | 9 | $313 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $236 |
| Gilead Sciences, Inc. | 4 | $209 |
| Phathom Pharmaceuticals, Inc. | 3 | $141 |
| QOL Medical, LLC | 6 | $139 |
| Curonix LLC | 1 | $130 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, Wegovy, XIFAXAN, RINVOQ, DUPIXENT, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
